Breast Cancer · 2020 · 22 citations · 28 references
PharmacyImmunologyMedicinal ChemistryCancer ImmunologyMonoclonal AntibodiesTumor ImmunologyAntibody CharacterizationAntibody ConjugatesAntibody ConjugationAntibody DiscoveryAntibody-drug Conjugate PharmacokineticsAntibody-drug ConjugatesAntibody-drug Conjugate AntibodiesAntibody-drug Conjugate MetabolismAntibody-drug Conjugate TherapyConjugate CharacterizationConjugated Antibodies
28
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2020 · 21.4K citations · Full text
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma, David Miles, Luca Gianni et al. · New England Journal of Medicine · 2012 · 3.8K citations · Full text
Medicine, Oncology, Pharmacology +14
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Shanu Modi, Cristina Saura, Toshinari Yamashita et al. · New England Journal of Medicine · 2019 · 2K citations · Full text
Medicine, Oncology, Pharmacology +17